C$0.035 AIML.CN AI/ML Innovations Inc. (CNQ) 21 Mar 2026: Low-priced AI stock merits close monitoring

AIML.CN stock trades at C$0.035 on the CNQ in Canada and sits near its 52-week low after longer-term declines. Investors focused on AI stocks will note the tiny market cap C$5,889,240.00 and negative earnings per share EPS -0.03. This profile combines valuation, liquidity, sector context and a model forecast to show why AIML.CN stock remains a high-risk, speculative exposure in digital health AI.

AIML.CN stock snapshot and recent price action

AI/ML Innovations Inc. (AIML.CN) opened at C$0.040 and trades between C$0.035 and C$0.04 today on the CNQ in Canada. The company’s year high is C$0.12 and year low is C$0.03, with today’s volume at 35,000.00 versus average volume 421,658.00. The low relative volume and sub-penny price indicate limited trading liquidity and higher execution risk for larger orders.

Financials and valuation metrics for AIML.CN stock

AI/ML Innovations reports EPS -0.03 and a trailing PE of -1.17, reflecting losses. The company shows cash per share C$0.005 and book value per share C$0.007. Market cap is C$5,889,240.00 with 168,264,000.00 shares outstanding. Price-to-sales reads roughly 35.00 and price-to-book is 4.58, which imply the market prices a recovery into future revenue growth rather than current earnings.

Technical, liquidity and trading signals for AIML.CN stock

Momentum indicators are weak with RSI 43.36 and ADX 16.78, showing no clear trend. The 50-day average price is 0.037 and the 200-day average is 0.046, both above the current price. On-chain volume metrics show on-balance volume near 311,974.00, but relative volume is 0.02, confirming quiet trading. Low liquidity magnifies volatility for AIML.CN stock.

Sector context and competitive position for AIML.CN stock

AI/ML Innovations operates in Healthcare digital services and wearable tech within Medical – Healthcare Information Services. The broader Canadian healthcare sector carries average PE 18.68 and average current ratio 1.89. AIML.CN stock shows a stronger current ratio of 2.09 but trailing margins are negative at -39.10%, underscoring the company’s early-stage commercial profile relative to peers.

Meyka AI rates and model forecast for AIML.CN stock

Meyka AI rates AIML.CN with a score of 62.11 out of 100 — Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of C$0.022, implying about -37.14% from the current C$0.035. Forecasts are model-based projections and not guarantees.

Risks, catalysts and price targets for AIML.CN stock

Key risks include persistent operating losses, limited liquidity, and thin revenue per share 0.001. Catalysts would be regulatory approvals, commercial contracts for the wearable platform, or meaningful revenue growth. Our working price targets: conservative C$0.02, base-case C$0.04, and upside C$0.10 if product adoption scales. These targets reflect the company’s small market cap and binary growth path.

Final Thoughts

AIML.CN stock at C$0.035 presents a speculative AI/healthcare exposure with clear downsides and a narrow set of upside scenarios. Financials show negative EPS -0.03, a trailing PE of -1.17, and thin revenues, while sector peers trade at materially higher multiples. Liquidity is low with average volume 421,658.00 and current volume 35,000.00, raising execution risk. Meyka AI’s forecast model projects C$0.022 over one year, implying approximately -37.14% versus today’s price. Our price band is C$0.02 to C$0.10, driven by commercial adoption or failure to scale. Investors in AIML.CN stock should treat it as a high-volatility, speculative holding and monitor quarterly updates, revenue traction and any partnering announcements before increasing position size. Meyka AI provides this AI-powered market analysis as one input; forecasts are model-based and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.